These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35368958)

  • 1. SPINK5 is a Tumor-Suppressor Gene Involved in the Progression of Nonsmall Cell Lung Carcinoma through Negatively Regulating PSIP1.
    Zhang J; Rong J; Ge W; Wang J; Wang W; Chi H
    J Healthc Eng; 2022; 2022():2209979. PubMed ID: 35368958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.
    Chen J; Lu J; Chen Z; Liu Z; Sun Y; He S; Mi Y; Gao Y; Shen D; Lin Q
    J Gene Med; 2024 Mar; 26(3):e3667. PubMed ID: 38442944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer.
    Wang Q; Lv Q; Bian H; Yang L; Guo KL; Ye SS; Dong XF; Tao LL
    Cancer Med; 2019 May; 8(5):2360-2371. PubMed ID: 30868765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
    Luo T; Yan L; Liu H
    J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.
    Sun S; Su G; Zheng X
    Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEBPB knockdown sensitizes nasopharyngeal carcinoma cells to cisplatin by promoting the expression of serine protease inhibitor Kazal-type 5.
    Liu H; Huang Q; Lv Y; Dong Y; Song D
    Anticancer Drugs; 2022 Jan; 33(1):e327-e335. PubMed ID: 34387602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
    Zhang MY; Lin J; Kui YC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 5.
    Zhang G; Zheng H; Wang L
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
    Sun B; Zhao J; Shao ZY
    Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3083-3090. PubMed ID: 35587058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1.
    Wang S; Sun H; Zhan X; Wang Q
    Int J Mol Med; 2020 Jan; 45(1):33-44. PubMed ID: 31746372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.